Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hepatitis C and injecting drug use: The realities of stigmatisation and discrimination

Identifieur interne : 002A83 ( Main/Exploration ); précédent : 002A82; suivant : 002A84

Hepatitis C and injecting drug use: The realities of stigmatisation and discrimination

Auteurs : Shah E. Habib [Bangladesh] ; Lester V. Adorjany [Australie]

Source :

RBID : ISTEX:CF97B330DA7BE5E1B917C3D9B7DA59E52754E3DE

English descriptors

Abstract

Objective To examine the extent of discrimination and stigmatisation related to hepatitis C virus (HCV) infection, as experienced by injecting drug users in Sydney, Australia. Design Data were collected through a self-administered questionnaire from injecting drug users (IDUs). Questions included basic demo- graphics, injecting and sexual history, HCV knowledge, risk practices, self-reported HCV diagnosis, and experiences of discrimination and o stigmatisation, as well as harm reduction services provided by needle and syringe programmes (NSPs). Both qualitative and quantitative data were collected from IDUs. Setting Questionnaires were distributed to clients of NSPs in the Sydney metropolitan area. Method Ten NSPs and one methadone clinic were selected. Questionnaires were distributed to all of these outlets and a total of 274 persons were recruited. The staff at the selected sites asked clients to fill out the questionnaire while distributing injecting equipment. Results Most HCV related discrimination against drug users was reported in health care settings. Fifty-two per cent of the participants experienced this as a result of being HCV positive. In addition, more than half of the sample (65 per cent) reported that such discrimination was actually as a result of being a drug user. Females were more likely than males to experience discrimination because of their HCV status. Conclusion The level of discrimination and stigmatisation was widespread in health care settings, resulting from the stereotyping of IDUs. The barriers to IDUs accessing health services need to be identified and removed. Implementation of an awareness campaign among health professionals would be a feasible way to address this issue.

Url:
DOI: 10.1177/001789690306200307


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Hepatitis C and injecting drug use: The realities of stigmatisation and discrimination</title>
<author wicri:is="90%">
<name sortKey="Habib, Shah E" sort="Habib, Shah E" uniqKey="Habib S" first="Shah E." last="Habib">Shah E. Habib</name>
</author>
<author wicri:is="90%">
<name sortKey="Adorjany, Lester V" sort="Adorjany, Lester V" uniqKey="Adorjany L" first="Lester V." last="Adorjany">Lester V. Adorjany</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CF97B330DA7BE5E1B917C3D9B7DA59E52754E3DE</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1177/001789690306200307</idno>
<idno type="url">https://api.istex.fr/ark:/67375/M70-018B1Q1J-5/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000918</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000918</idno>
<idno type="wicri:Area/Istex/Curation">000912</idno>
<idno type="wicri:Area/Istex/Checkpoint">001521</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001521</idno>
<idno type="wicri:doubleKey">0017-8969:2003:Habib S:hepatitis:c:and</idno>
<idno type="wicri:Area/Main/Merge">002A93</idno>
<idno type="wicri:Area/Main/Curation">002A83</idno>
<idno type="wicri:Area/Main/Exploration">002A83</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Hepatitis C and injecting drug use: The realities of stigmatisation and discrimination</title>
<author wicri:is="90%">
<name sortKey="Habib, Shah E" sort="Habib, Shah E" uniqKey="Habib S" first="Shah E." last="Habib">Shah E. Habib</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Bangladesh</country>
<wicri:regionArea>Department of Sociology, University of Rajshahi</wicri:regionArea>
<wicri:noRegion>University of Rajshahi</wicri:noRegion>
</affiliation>
</author>
<author wicri:is="90%">
<name sortKey="Adorjany, Lester V" sort="Adorjany, Lester V" uniqKey="Adorjany L" first="Lester V." last="Adorjany">Lester V. Adorjany</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Sociology, University of New South Wales, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Health Education Journal</title>
<idno type="ISSN">0017-8969</idno>
<idno type="eISSN">1748-8176</idno>
<imprint>
<publisher>Sage Publications</publisher>
<pubPlace>Sage CA: Thousand Oaks, CA</pubPlace>
<date type="published" when="2003-09">2003-09</date>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="256">256</biblScope>
<biblScope unit="page" to="265">265</biblScope>
</imprint>
<idno type="ISSN">0017-8969</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0017-8969</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Awareness campaign</term>
<term>Basic demographics</term>
<term>Clinical research</term>
<term>Commonwealth department</term>
<term>Discrimination</term>
<term>Drug user</term>
<term>Drug users</term>
<term>Experience discrimination</term>
<term>Harm reduction services</term>
<term>Health care</term>
<term>Health care settings</term>
<term>Health professionals</term>
<term>Health status</term>
<term>Hepatitis</term>
<term>Idus</term>
<term>Idus accessing health services need</term>
<term>Life insurance</term>
<term>Limited range</term>
<term>Many people</term>
<term>Methadone</term>
<term>Methadone clinic</term>
<term>National centre</term>
<term>Nsps</term>
<term>Positive people</term>
<term>Positive user</term>
<term>Private clinics</term>
<term>Public health</term>
<term>Publications production unit</term>
<term>Quantitative data</term>
<term>Risk practices</term>
<term>Service providers</term>
<term>Social isolation</term>
<term>Social issues</term>
<term>Social science medicine</term>
<term>Stigmatisation</term>
<term>Such discrimination</term>
<term>Support services</term>
<term>Sydney</term>
<term>Syringe programmes</term>
<term>User</term>
<term>Virus infection</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Objective To examine the extent of discrimination and stigmatisation related to hepatitis C virus (HCV) infection, as experienced by injecting drug users in Sydney, Australia. Design Data were collected through a self-administered questionnaire from injecting drug users (IDUs). Questions included basic demo- graphics, injecting and sexual history, HCV knowledge, risk practices, self-reported HCV diagnosis, and experiences of discrimination and o stigmatisation, as well as harm reduction services provided by needle and syringe programmes (NSPs). Both qualitative and quantitative data were collected from IDUs. Setting Questionnaires were distributed to clients of NSPs in the Sydney metropolitan area. Method Ten NSPs and one methadone clinic were selected. Questionnaires were distributed to all of these outlets and a total of 274 persons were recruited. The staff at the selected sites asked clients to fill out the questionnaire while distributing injecting equipment. Results Most HCV related discrimination against drug users was reported in health care settings. Fifty-two per cent of the participants experienced this as a result of being HCV positive. In addition, more than half of the sample (65 per cent) reported that such discrimination was actually as a result of being a drug user. Females were more likely than males to experience discrimination because of their HCV status. Conclusion The level of discrimination and stigmatisation was widespread in health care settings, resulting from the stereotyping of IDUs. The barriers to IDUs accessing health services need to be identified and removed. Implementation of an awareness campaign among health professionals would be a feasible way to address this issue.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Bangladesh</li>
</country>
<region>
<li>Nouvelle-Galles du Sud</li>
</region>
<settlement>
<li>Sydney</li>
</settlement>
</list>
<tree>
<country name="Bangladesh">
<noRegion>
<name sortKey="Habib, Shah E" sort="Habib, Shah E" uniqKey="Habib S" first="Shah E." last="Habib">Shah E. Habib</name>
</noRegion>
</country>
<country name="Australie">
<region name="Nouvelle-Galles du Sud">
<name sortKey="Adorjany, Lester V" sort="Adorjany, Lester V" uniqKey="Adorjany L" first="Lester V." last="Adorjany">Lester V. Adorjany</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A83 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002A83 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:CF97B330DA7BE5E1B917C3D9B7DA59E52754E3DE
   |texte=   Hepatitis C and injecting drug use: The realities of stigmatisation and discrimination
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021